{"id":"antidepressant-drug-therapy","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Sexual dysfunction"},{"rate":null,"effect":"Insomnia or somnolence"},{"rate":null,"effect":"Weight gain or loss"}]},"_chembl":{"chemblId":"CHEMBL157030","moleculeType":"Small molecule","molecularWeight":"883.99"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is a broad category rather than a single drug, encompassing multiple classes (SSRIs, SNRIs, tricyclics, MAOIs, etc.) that increase availability of serotonin, norepinephrine, or dopamine in synaptic spaces. The exact mechanism depends on the specific antidepressant class employed in the University of Washington phase 3 trial, but generally involves reuptake inhibition or monoamine oxidase inhibition to enhance mood regulation and emotional processing.","oneSentence":"Antidepressant drug therapy works by modulating neurotransmitter levels in the brain to alleviate symptoms of depression.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:01:53.210Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"}]},"trialDetails":[{"nctId":"NCT07494305","phase":"PHASE2","title":"Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.","status":"RECRUITING","sponsor":"LB Pharmaceuticals Inc.","startDate":"2026-01-23","conditions":"Bipolar I Disorder","enrollment":320},{"nctId":"NCT07361796","phase":"NA","title":"The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-12-15","conditions":"Herpes Zoster, Pain, Postherpetic Neuralgia","enrollment":832},{"nctId":"NCT07480486","phase":"NA","title":"Pharmacogenetic-Guided Antidepressant Treatment in Depression","status":"NOT_YET_RECRUITING","sponsor":"Mohammed V University in Rabat","startDate":"2026-04-01","conditions":"Depression - Major Depressive Disorder","enrollment":570},{"nctId":"NCT07226661","phase":"PHASE2","title":"Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder","status":"RECRUITING","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2026-01-19","conditions":"Major Depressive Disorder (MDD)","enrollment":230},{"nctId":"NCT07174947","phase":"PHASE2","title":"SSRI Antidepressant Fluoxetine Improving Immunotherapy Efficacy in Advanced Hepatobiliary Malignancy Patients With Depression and Anxiety","status":"RECRUITING","sponsor":"First Affiliated Hospital of Wenzhou Medical University","startDate":"2025-10-01","conditions":"Hepatobiliary Malignancy, Fluoxetine, Anxiety Disorders","enrollment":240},{"nctId":"NCT06731621","phase":"PHASE1","title":"Psilocybin for Treatment-Resistant Depression in Autism","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-11-01","conditions":"Treatment Resistant Depression, Autism Spectrum Disorder","enrollment":20},{"nctId":"NCT06340958","phase":"PHASE2","title":"A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder","status":"COMPLETED","sponsor":"Clexio Biosciences Ltd.","startDate":"2024-03-18","conditions":"Adjunctive Treatment of Major Depressive Disorder (MDD)","enrollment":99},{"nctId":"NCT03844412","phase":"PHASE2","title":"Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments","status":"COMPLETED","sponsor":"Duke University","startDate":"2019-11-04","conditions":"Vestibulodynia, Temporomandibular Disorder, Fibromyalgia Syndrome","enrollment":209},{"nctId":"NCT07396272","phase":"PHASE2","title":"A Clinical Trial of Add-on Oral Slow-release Ketamine Treatment in Major Depression","status":"RECRUITING","sponsor":"Daniel Lindqvist","startDate":"2026-04-01","conditions":"Major Depressive Disorder (MDD)","enrollment":12},{"nctId":"NCT07345117","phase":"NA","title":"Cost-effectiveness and Implementation of a Transdiagnostic Internet-based Intervention for Emotional Disorders in Community Care.","status":"NOT_YET_RECRUITING","sponsor":"Universitat Jaume I","startDate":"2026-04-01","conditions":"Emotional Disorders, Depression Anxiety Disorder, Depression Disorders","enrollment":200},{"nctId":"NCT07480525","phase":"NA","title":"Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Peking University","startDate":"2026-03-20","conditions":"Depression - Major Depressive Disorder","enrollment":200},{"nctId":"NCT07015944","phase":"NA","title":"Moving on After Breast Cancer Trial for Depressed Breast Cancer Survivors in Pakistan","status":"RECRUITING","sponsor":"Pakistan Institute of Living and Learning","startDate":"2025-06-13","conditions":"Major Depressive Disorder (MDD), Breast Cancer Survivor","enrollment":26376},{"nctId":"NCT06559306","phase":"PHASE3","title":"Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-07-25","conditions":"Depressive Disorder, Major","enrollment":752},{"nctId":"NCT06580860","phase":"","title":"Psychiatric Multi-omics and Neuroimaging Project","status":"RECRUITING","sponsor":"mingjun Zhong","startDate":"2016-01","conditions":"Mental Disorders, Healthy Control","enrollment":1899},{"nctId":"NCT05841030","phase":"","title":"A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2023-04-28","conditions":"Depressive Disorder, Major","enrollment":545},{"nctId":"NCT07452341","phase":"NA","title":"Effect of Virtual Reality on Depression in Adolescent Females","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-08-01","conditions":"Depression","enrollment":48},{"nctId":"NCT06604520","phase":"PHASE2","title":"Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-03-20","conditions":"Fronto-temporal Dementia, Fronto-temporal Lobar Dementia, Frontotemporal Degeneration","enrollment":50},{"nctId":"NCT06408246","phase":"PHASE2","title":"ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression","status":"RECRUITING","sponsor":"Stanford University","startDate":"2026-03-03","conditions":"Depression","enrollment":162},{"nctId":"NCT05710887","phase":"PHASE2","title":"N2O for Acute Suicidality and Depression in the ED","status":"WITHDRAWN","sponsor":"University of Chicago","startDate":"2026-02-27","conditions":"Suicidal Ideation, Major Depressive Disorder, Treatment Resistant Depression","enrollment":""},{"nctId":"NCT06832605","phase":"NA","title":"Mindfulness-Based Cognitive Therapy (MBCT) for the Prevention of Depression Relapse or Recurrence Using Videoconference","status":"NOT_YET_RECRUITING","sponsor":"Fundació Sant Joan de Déu","startDate":"2026-04","conditions":"Major Depressive Disorder, Recurrent, in Remission","enrollment":315},{"nctId":"NCT03973268","phase":"PHASE1","title":"Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2020-01-21","conditions":"Depression, Major Depressive Disorder, Major Depression","enrollment":70},{"nctId":"NCT07430046","phase":"PHASE2","title":"Repurposing Mirtazapine in Rett Syndrome","status":"RECRUITING","sponsor":"University of Trieste","startDate":"2025-07-09","conditions":"RETT Syndrome With Proven MECP2 Mutation","enrollment":54},{"nctId":"NCT05593029","phase":"PHASE2","title":"A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2022-11-09","conditions":"Major Depressive Disorder","enrollment":929},{"nctId":"NCT07076342","phase":"PHASE4","title":"The Role of mGluR5 in CBT-I","status":"RECRUITING","sponsor":"Stony Brook University","startDate":"2025-08-01","conditions":"Major Depressive Disorder (MDD)","enrollment":42},{"nctId":"NCT06514742","phase":"PHASE3","title":"A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2024-06-26","conditions":"Depressive Disorder, Major, Anhedonia","enrollment":101},{"nctId":"NCT05550532","phase":"PHASE3","title":"A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2022-12-06","conditions":"Depressive Disorder, Major, Anhedonia","enrollment":444},{"nctId":"NCT07373470","phase":"NA","title":"An Evaluation of the Impact of Pharmacist Comprehensive Medication Management With Pharmacogenomic Results to Improve Depression Outcomes in Community Pharmacies.","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2026-03","conditions":"Pharmacogenetics, Depression - Major Depressive Disorder, Pharmacogenomic Drug Interaction","enrollment":220},{"nctId":"NCT06993662","phase":"PHASE1","title":"The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rakitzi, Stavroula","startDate":"2025-06-02","conditions":"Anxiety, Depression, Obsessive-compulsive Disorder","enrollment":107},{"nctId":"NCT07047651","phase":"PHASE4","title":"Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR.","status":"RECRUITING","sponsor":"Dr. Stavroula Rakitzi","startDate":"2025-06-04","conditions":"Treatment Resistant Schizophrenia, Treatment Resistant Bipolar Disorder","enrollment":40},{"nctId":"NCT03674138","phase":"NA","title":"Pharmacogenomic-Guided Antidepressant Drug Prescribing in Cancer Patients","status":"COMPLETED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-09-12","conditions":"Depression, Anxiety, Generalized Anxiety Disorder","enrollment":99},{"nctId":"NCT06731101","phase":"NA","title":"Stellate Ganglion Block Versus Oral Medication in Treatment of Palmar Hyperhidrosis","status":"COMPLETED","sponsor":"Fayoum University","startDate":"2025-01-15","conditions":"Palmar Hyperhidrosis","enrollment":46},{"nctId":"NCT07384273","phase":"NA","title":"Evaluating the Effectiveness of an Internet-based Therapy (iCARE) to Treat Symptoms of Postpartum Depression","status":"RECRUITING","sponsor":"University of Southern Denmark","startDate":"2026-02-01","conditions":"Postpartum Depression (PPD)","enrollment":352},{"nctId":"NCT06524830","phase":"PHASE2","title":"A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)","status":"RECRUITING","sponsor":"atai Therapeutics, Inc.","startDate":"2024-12-30","conditions":"Treatment Resistant Depression","enrollment":142},{"nctId":"NCT07384312","phase":"NA","title":"Study on the Antidepressant Effects and Mechanism of Action of Cang-ai Volatile Oil Based on Near-Infrared Functional Brain Imaging and the NT-Trk Signalling Pathway","status":"COMPLETED","sponsor":"Dongdong Qin","startDate":"2023-10-01","conditions":"Depression Disorder","enrollment":60},{"nctId":"NCT05814640","phase":"PHASE1, PHASE2","title":"Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)","status":"RECRUITING","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2023-02-20","conditions":"Depression, Sequestra","enrollment":520},{"nctId":"NCT07228468","phase":"NA","title":"Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)","status":"RECRUITING","sponsor":"King's College London","startDate":"2025-11-18","conditions":"Major Depressive Disorder (MDD)","enrollment":438},{"nctId":"NCT06846320","phase":"PHASE2","title":"Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder","status":"RECRUITING","sponsor":"AbbVie","startDate":"2025-04-29","conditions":"Generalized Anxiety Disorder (GAD)","enrollment":315},{"nctId":"NCT06404099","phase":"PHASE2","title":"RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2024-08-12","conditions":"Long COVID, Long COVID-19, Hypersomnia","enrollment":361},{"nctId":"NCT06937476","phase":"NA","title":"Neurobiological Mechanisms of Pathological Rumination and Effects of Aripiprazole","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-05-08","conditions":"Major Depressive Disorder (MDD), Rumination","enrollment":108},{"nctId":"NCT05603104","phase":"PHASE3","title":"Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2025-04-27","conditions":"Schizophrenia and Related Disorders, Major Depressive Disorder, Bipolar Depression","enrollment":1254},{"nctId":"NCT06404086","phase":"PHASE2","title":"RECOVER-SLEEP: Platform Protocol","status":"COMPLETED","sponsor":"Duke University","startDate":"2024-07-31","conditions":"Long COVID, Long COVID-19, Hypersomnia","enrollment":830},{"nctId":"NCT04747314","phase":"PHASE2, PHASE3","title":"Treating Negative Affect in Low Back Pain Patients","status":"COMPLETED","sponsor":"Ajay Wasan, MD, Msc","startDate":"2021-03-31","conditions":"Chronic Low Back Pain, Negative Affectivity","enrollment":308},{"nctId":"NCT05357040","phase":"PHASE2","title":"Antidepressant Effects of Nitrous Oxide","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2021-06-30","conditions":"Major Depressive Disorder, Treatment Resistant Depression","enrollment":172},{"nctId":"NCT07328373","phase":"","title":"Neurobiological and Genomic Predictors of Relapse in Depression","status":"RECRUITING","sponsor":"Mehmet Kemal Arikan","startDate":"2025-01-01","conditions":"Healthy, Major Depressive Disorder (MDD)","enrollment":204},{"nctId":"NCT06450704","phase":"NA","title":"Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders","status":"RECRUITING","sponsor":"Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","startDate":"2025-04-21","conditions":"Major Depressive Disorder, Inflammatory Response","enrollment":124},{"nctId":"NCT06672419","phase":"NA","title":"Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)","status":"NOT_YET_RECRUITING","sponsor":"Instituto Neurociencia Del Dolor","startDate":"2026-02-01","conditions":"Fibromyalgia, Fibromyalgia Syndrome","enrollment":50},{"nctId":"NCT07115381","phase":"NA","title":"A Study on the Intervention Effect of Therapeutic Horticulture Based on the Healing System on Non-suicidal Self-injury in Adolescent Patients With Depression","status":"NOT_YET_RECRUITING","sponsor":"Lei Huang","startDate":"2026-02","conditions":"Depression","enrollment":66},{"nctId":"NCT07003763","phase":"NA","title":"Electroacupuncture on Treating Cancer-related Depression","status":"RECRUITING","sponsor":"Shanghai Municipal Hospital of Traditional Chinese Medicine","startDate":"2025-07-01","conditions":"Depression, Cancer","enrollment":86},{"nctId":"NCT00792168","phase":"PHASE4","title":"Physiologic Monitoring of Antidepressant Response","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"1996-11","conditions":"Major Depression","enrollment":38},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT07180342","phase":"NA","title":"An Empirical Study on the Mechanisms of Biopsychosocial Functional Improvement in Patients With Major Depressive Disorder Through Nature-Based Tourism Activities","status":"RECRUITING","sponsor":"Shandong Provincial Hospital","startDate":"2025-10-09","conditions":"Major Depressive Disorder","enrollment":86},{"nctId":"NCT04491045","phase":"NA","title":"Implementation Strategies for Task-Shifting Depression Care Depression Care in Vietnam","status":"COMPLETED","sponsor":"City University of New York, School of Public Health","startDate":"2021-12-01","conditions":"Depression","enrollment":1382},{"nctId":"NCT06034821","phase":"PHASE4","title":"Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan","status":"ENROLLING_BY_INVITATION","sponsor":"Brigham and Women's Hospital","startDate":"2023-10-01","conditions":"Acute Suicidal Depression (ASD)","enrollment":1500},{"nctId":"NCT05966532","phase":"","title":"Emotional Cognition: Establishing Constructs and Neural-Behavioral Mechanisms in Older Adults With Depression","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-12-11","conditions":"Major Depressive Disorder (MDD), Healthy Adult Volunteer","enrollment":276},{"nctId":"NCT03640624","phase":"NA","title":"Multidisciplinary Treatment of Chronic Vulvar Pain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Norwegian University of Science and Technology","startDate":"2018-09-18","conditions":"Vulvodynia, Chronic Pain","enrollment":106},{"nctId":"NCT03553095","phase":"NA","title":"Comparing Inflammatory Markers in Patients With and Without Depression With Chronic Periodontitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2018-07-12","conditions":"Chronic Periodontitis, Depression","enrollment":92},{"nctId":"NCT06907134","phase":"NA","title":"The Purpose of the Study is to Investigate if a Smartphone App Combined With Internet Based Cognitive Behavioural Therapy (ICBT) Leads to Improved Symtoms in Depressive Adults on Antidepressive Medicine, Compared to a Wait-list Control Condition","status":"ACTIVE_NOT_RECRUITING","sponsor":"Linkoeping University","startDate":"2024-11-02","conditions":"Depressive Symptoms","enrollment":150},{"nctId":"NCT06692361","phase":"NA","title":"Assessment of the Efficacy and Safety of Fecal Microbiota Transplantation (FMT) in Patients With Major Depressive Disorder","status":"RECRUITING","sponsor":"Gang Wang","startDate":"2025-01-01","conditions":"Major Depressive Disorder (MDD), Depression - Major Depressive Disorder","enrollment":214},{"nctId":"NCT05732298","phase":"NA","title":"Theta Burst Stimulation in Pharmacologically Untreated Patients as Sole Antidepressant Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Regensburg","startDate":"2023-02-27","conditions":"Depression","enrollment":72},{"nctId":"NCT07239011","phase":"PHASE1, PHASE2","title":"Dapagliflozin in Depression","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-11-01","conditions":"Depression","enrollment":60},{"nctId":"NCT06384209","phase":"NA","title":"The Friendship Bench Plus Trial","status":"RECRUITING","sponsor":"University of Bern","startDate":"2025-06-26","conditions":"Major Depressive Disorder, Severe Depressive Episode Without Psychotic Symptoms","enrollment":296},{"nctId":"NCT06831942","phase":"NA","title":"Attempted Suicide Short Intervention Program for Older Adults (ASSIP-OA): An Evaluation of a Psychosocial Intervention for Suicidal Adults Aged 65+","status":"RECRUITING","sponsor":"Vastra Gotaland Region","startDate":"2025-10-01","conditions":"Suicidal Ideation, Suicide Attempt, Suicide","enrollment":132},{"nctId":"NCT05455684","phase":"PHASE3","title":"A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2022-06-22","conditions":"Depressive Disorder, Major, Anhedonia","enrollment":513},{"nctId":"NCT05944926","phase":"PHASE3","title":"Improving Outcomes in Depression in Primary Care in a Low Resource Setting","status":"RECRUITING","sponsor":"Harvard Medical School (HMS and HSDM)","startDate":"2024-03-18","conditions":"Depression, Depressive Disorder","enrollment":1500},{"nctId":"NCT05575128","phase":"NA","title":"Behavioral Activation and Medication Optimization In Older Adults Undergoing Cardiac Procedures","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2022-11-05","conditions":"Cardiac Surgery, Older Adults, Depression","enrollment":102},{"nctId":"NCT04103892","phase":"PHASE2","title":"A Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study","status":"COMPLETED","sponsor":"Clexio Biosciences Ltd.","startDate":"2019-09-05","conditions":"Adjunctive Treatment of Major Depressive Disorder","enrollment":146},{"nctId":"NCT04560660","phase":"PHASE2","title":"Ketamine-enhanced Prolonged Exposure Therapy in PTSD","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2021-03-09","conditions":"PTSD","enrollment":75},{"nctId":"NCT05989451","phase":"NA","title":"Adaptation of Individual Dialectical Behavior Therapy Intervention for Transdiagnostic Treatment of Emotional Disorders","status":"RECRUITING","sponsor":"Mackay Memorial Hospital","startDate":"2023-09-01","conditions":"Anxiety Disorder, Depressive Disorder","enrollment":250},{"nctId":"NCT04111627","phase":"PHASE2","title":"Exercise Plus Duloxetine for Knee Osteoarthritis","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2021-10-07","conditions":"Knee Osteoarthritis, Depression","enrollment":43},{"nctId":"NCT05415397","phase":"PHASE3","title":"Treating Immuno-metabolic Depression With Anti-inflammatory Drugs","status":"RECRUITING","sponsor":"Amsterdam UMC, location VUmc","startDate":"2022-09-28","conditions":"Depressive Disorder, Major, Inflammation","enrollment":140},{"nctId":"NCT02751632","phase":"PHASE3","title":"The Staged Treatment in Early Psychosis Study","status":"COMPLETED","sponsor":"Orygen","startDate":"2016-04","conditions":"Psychotic Disorders, Personality Disorders, Clinical High Risk","enrollment":342},{"nctId":"NCT06049953","phase":"","title":"Maternal And Infant Antipsychotic Study","status":"RECRUITING","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2023-09-29","conditions":"Antipsychotics, Pregnancy","enrollment":200},{"nctId":"NCT05973851","phase":"PHASE3","title":"The Effect of a Six Week Intensified Pharmacological Treatment for Major Depressive Disorder Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment.","status":"RECRUITING","sponsor":"Dr. Inge Winter","startDate":"2024-08-31","conditions":"Major Depressive Disorder, Treatment Resistant Depression","enrollment":418},{"nctId":"NCT07192367","phase":"PHASE4","title":"Comparison of the Effectiveness Level of Virtual Reality Exposure Therapy With Sertraline Treatment in Social Anxiety Disorder","status":"RECRUITING","sponsor":"Emine Kanmaz","startDate":"2024-11-15","conditions":"Social Anxiety Disorder","enrollment":56},{"nctId":"NCT05630469","phase":"","title":"Prediction of Antidepressant Effects of Electroconvulsive Therapy","status":"RECRUITING","sponsor":"Medical University of Vienna","startDate":"2022-12-01","conditions":"Depressive Disorder, Major","enrollment":30},{"nctId":"NCT02809677","phase":"NA","title":"Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2016-06","conditions":"Asthma, Major Depressive Disorder","enrollment":205},{"nctId":"NCT02863380","phase":"NA","title":"Personalized rTMS for Resistant Depression","status":"TERMINATED","sponsor":"University Hospital, Strasbourg, France","startDate":"2016-05-04","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":27},{"nctId":"NCT00285935","phase":"NA","title":"Cellular Aging and Neurobiology of Depression Study","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2010-12-16","conditions":"Major Depressive Disorder","enrollment":228},{"nctId":"NCT06707012","phase":"PHASE4","title":"Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients","status":"RECRUITING","sponsor":"Fazaia Ruth Pfau Medical College","startDate":"2025-10-01","conditions":"Depression","enrollment":140},{"nctId":"NCT06443242","phase":"NA","title":"Efficacy and Safety of Low-dose Laser Acupuncture on Treating Insomnia Associated With Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Mohammad Farris Iman Leong Bin Abdullah","startDate":"2025-12-01","conditions":"Major Depressive Disorder, Insomnia","enrollment":120},{"nctId":"NCT07161492","phase":"NA","title":"A Study on Functional Connectome and rTMS Intervention of Cognitive Flexibility Impairment in Patients With Major Depressive Disorder","status":"NOT_YET_RECRUITING","sponsor":"Second Xiangya Hospital of Central South University","startDate":"2025-09","conditions":"Depressive Disorder, Major, Cognitive Impairment","enrollment":182},{"nctId":"NCT06746441","phase":"PHASE2","title":"Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers","status":"COMPLETED","sponsor":"Khyber Medical University Peshawar","startDate":"2024-12-01","conditions":"Major Depressive Disorder","enrollment":60},{"nctId":"NCT05524519","phase":"NA","title":"Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive Disorder","status":"COMPLETED","sponsor":"The Third Affiliated hospital of Zhejiang Chinese Medical University","startDate":"2022-11-01","conditions":"Major Depressive Disorder","enrollment":160},{"nctId":"NCT06001021","phase":"NA","title":"Cognitive Behavioral Couple Therapy for Perinatal Distress","status":"COMPLETED","sponsor":"Sameera Shafiq","startDate":"2023-08-15","conditions":"Perinatal Depression, Perinatal Anxiety","enrollment":96},{"nctId":"NCT07120880","phase":"PHASE3","title":"Efficacy of Chronotherapeutic Combination for Major Depressive Episode With Insomnia","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-09","conditions":"Major Depressive Disorder (MDD) With Insomnia","enrollment":184},{"nctId":"NCT04513912","phase":"PHASE3","title":"A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-15","conditions":"Depressive Disorder, Major","enrollment":757},{"nctId":"NCT07097025","phase":"","title":"2-Year Study of Vagus Nerve Stimulation for Higher-Grade Treatment-Resistant Depression: Clinical Outcomes and Policy Recommendation","status":"COMPLETED","sponsor":"Dr.Yoav Domany","startDate":"2020-01-01","conditions":"Treatment Resistant Depression (TRD), Depression - Major Depressive Disorder, Bipolar Depression","enrollment":19},{"nctId":"NCT07105397","phase":"NA","title":"Evaluating Conversational Artificial Intelligence for Depression Management","status":"NOT_YET_RECRUITING","sponsor":"George Mason University","startDate":"2026-04-15","conditions":"Major Depressive Disorder (MDD)","enrollment":130},{"nctId":"NCT06144294","phase":"NA","title":"Whole-Body Hyperthermia for Mood and Anxiety Disorders","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-06","conditions":"Postpartum Depression, Mood Disorders, Anxiety Disorders","enrollment":240},{"nctId":"NCT07088380","phase":"PHASE3","title":"Ketamine Augmentation of ECT in Treatment-Resistant Depression","status":"RECRUITING","sponsor":"Università Vita-Salute San Raffaele","startDate":"2025-07-10","conditions":"Major Depressive Disorder, Treatment Resistant Depression","enrollment":30},{"nctId":"NCT06894680","phase":"NA","title":"Integrating Depression Care Into HIV Services for Older People With HIV Using a Stepped Care, Task-Sharing Approach.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Royal Society of Tropical Medicine and Hygiene","startDate":"2025-03-24","conditions":"Older Adults (50-90 Years), Depression","enrollment":120},{"nctId":"NCT07048938","phase":"NA","title":"Clinical Effect and Mechanism Study of Five Elements Music Therapy(FEMT) on Depression Disorder","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Mental Health Center","startDate":"2025-07-01","conditions":"Depression Disorder, Depression Disorders, Depressive Disorder","enrollment":120},{"nctId":"NCT06594588","phase":"NA","title":"Individualized Exploration of Aerobic Exercise-assisted Treatment of Depression","status":"RECRUITING","sponsor":"Peking University","startDate":"2024-09-12","conditions":"Depression - Major Depressive Disorder","enrollment":80},{"nctId":"NCT06756139","phase":"NA","title":"Effects of Cognitive Behavioral Therapy Through a Mobile App on Patients With Refractory Functional Dyspepsia","status":"RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2024-11-01","conditions":"Functional Dyspepsia, Self-help Mobile Cognitive Behavioral Therapy, Antipsychotic Drug","enrollment":88},{"nctId":"NCT07024303","phase":"EARLY_PHASE1","title":"Measurement of Treatment Effects","status":"NOT_YET_RECRUITING","sponsor":"Matthew J O'Brien, PhD, BCBA-D","startDate":"2025-06-15","conditions":"Challenging Behavior, Autism Spectrum Disorder","enrollment":20},{"nctId":"NCT04821271","phase":"PHASE2","title":"Antidepressant Effects of TS-161 in Treatment-Resistant Depression","status":"TERMINATED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2021-06-10","conditions":"Major Depressive Disorder, Treatment-Resistant Depression, Depression","enrollment":11},{"nctId":"NCT05697835","phase":"NA","title":"Perioperative Mental Health in Orthopedic Surgery","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2023-02-27","conditions":"Orthopedic Surgery, Older Adults, Depression","enrollment":104},{"nctId":"NCT07014241","phase":"NA","title":"Assessment of Whether Telehealth Family Psychoeducation for Major Depressive Disorder is Doable","status":"NOT_YET_RECRUITING","sponsor":"University of Southern Queensland","startDate":"2025-11","conditions":"Major Depressive Disorder (MDD)","enrollment":26},{"nctId":"NCT04899206","phase":"","title":"ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA","status":"WITHDRAWN","sponsor":"Sebastian Videla","startDate":"2021-04-12","conditions":"ACE Inhibitors, ARB, Hypertension","enrollment":""},{"nctId":"NCT04532749","phase":"PHASE3","title":"A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2020-09-15","conditions":"Depressive Disorder, Major","enrollment":212}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":182,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Sertraline, \"Zoloft\""],"phase":"phase_3","status":"active","brandName":"Antidepressant Drug Therapy","genericName":"Antidepressant Drug Therapy","companyName":"University of Washington","companyId":"university-of-washington","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Antidepressant drug therapy works by modulating neurotransmitter levels in the brain to alleviate symptoms of depression. Used for Major depressive disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}